[Cannabis use and untreated HIV-infection: unknown risk factors for premature peripheral artery disease]

M R M Scheltinga1, S van der Geer, E Hauben

  • 1Máixima Medisch Centrum, De Run 4600, 5504 DB, Veldhoven. m.scheltinga@mmc.nl

Insights

Untreated HIV infection and daily cannabis use in a young woman led to severe peripheral artery disease and amputation. Quitting cannabis improved symptoms, suggesting it as a key risk factor for non-atherosclerotic arterial disease.

Area of Science:

  • Vascular Medicine
  • Infectious Diseases
  • Toxicology

Background:

  • Peripheral artery disease (PAD) typically affects older individuals and is primarily caused by atherosclerosis.
  • Younger patients (<40 years) with PAD require exclusion of rare causes like inflammation or vascular injury.
  • Human immunodeficiency virus (HIV) infection and cannabis use are emerging, less recognized risk factors for premature arterial disease.

Observation:

  • A 32-year-old woman with untreated HIV for 8 years and 15 years of daily cannabis smoking presented with severe lower leg ischemia and gangrene.
  • Angiography revealed significant peripheral artery disease; despite a femorodistal bypass graft, amputation was necessary.
  • Histopathology showed intimal fibrosis, thrombosis with recanalization, and internal elastic membrane fragmentation, indicative of non-atherosclerotic arterial disease.

Findings:

  • The case highlights untreated HIV infection as a likely cause of premature, non-atherosclerotic peripheral artery disease.
  • Cannabis use is identified as a significant risk factor, with cessation showing a positive impact on ischemic symptoms.
  • Histopathological findings support a link between HIV and specific vascular changes leading to PAD.

Implications:

  • This case underscores the importance of considering HIV and cannabis use in young individuals presenting with PAD.
  • Further research is needed to elucidate the direct impact of HIV treatment on the progression of premature vascular disease.
  • Clinicians must weigh cardiovascular risks associated with antiretroviral therapy when managing HIV-infected patients with vascular complications.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...